Please check your internet connection and try again.
# Miconazole Vaginal Pessary
## Overview
Miconazole is an imidazole antifungal agent used for the topical treatment of vulvovaginal candidiasis (yeast infections).
## Primary Indications
Treatment of vulvovaginal candidiasis.
## Adult Dosing
* **100 mg vaginal pessary:** Insert one pessary vaginally at bedtime for 7 consecutive nights.
* **200 mg vaginal pessary:** Insert one pessary vaginally at bedtime for 3 consecutive nights.
* **100 mg vaginal suppository (may be referred to as a pessary):** Insert one suppository vaginally at bedtime for 7 consecutive nights.
* **200 mg vaginal suppository (may be referred to as a pessary):** Insert one suppository vaginally at bedtime for 3 consecutive nights.
* **Higher strength formulations (e.g., 1200 mg single-dose vaginal suppository):** Insert one suppository vaginally at bedtime as a single dose.
Follow specific product labeling for the exact dosage form and duration.
## Pediatric Dosing
Data for pediatric use of vaginal pessaries is limited. Dosing should be guided by product labeling and clinical judgment. Use in children is generally not recommended unless specifically indicated and managed by a healthcare professional.
## Dose Adjustments
No dose adjustments are typically necessary for hepatic or renal impairment due to minimal systemic absorption.
## Contraindications
* Known hypersensitivity to miconazole or any component of the formulation.
* Use with warfarin: Miconazole, especially when administered systemically or with significant topical absorption, can inhibit CYP2C9 and increase warfarin levels, posing a bleeding risk. Caution is advised.
## Adverse Effects
* **Common:** Vaginal burning, itching, irritation, redness, pelvic cramping.
* **Less Common:** Headache.
## Key Drug Interactions
* **Warfarin:** Miconazole can inhibit CYP2C9, increasing the anticoagulant effect of warfarin. Close monitoring of INR is recommended if used concurrently, and warfarin dose may need adjustment.
* **CYP3A4 Substrates:** Topical miconazole has the potential for systemic absorption, which could lead to interactions with other drugs metabolized by CYP3A4, although this is less likely with vaginal administration compared to oral.
## Monitoring
* Monitor for signs of local irritation or allergic reaction.
* If treating concurrent warfarin therapy, monitor INR closely.
## Clinical Pearls
* Complete the full course of therapy as directed, even if symptoms improve earlier.
* Avoid intercourse during treatment.
* Lubricated applicators may improve insertion comfort.
* Consider a 3-day or single-dose regimen for faster symptom relief if appropriate for the patient and the infection severity.
***
**Disclaimer:** This information is intended for healthcare professionals and is not a substitute for professional medical advice. Always consult with a qualified healthcare provider to ensure the most accurate and up-to-date information regarding drug therapy. Verify current prescribing information for any medication before use.
